Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia

Published:2011-07 Issue:7 Volume:1 Page:e28-e28
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Kaiser M,Kühnl A,Reins J,Fischer S,Ortiz-Tanchez J,Schlee C,Mochmann L H,Heesch S,Benlasfer O,Hofmann W-K,Thiel E,Baldus C D

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj201128.pdf

Reference46 articles.

1. Rowe JM, Tallman MS . How I treat acute myeloid leukemia. Blood 2010; 116: 3147–3156.

2. Gökbuget N, Hoelzer D . Treatment of adult acute lymphoblastic leukemia. Semin Hematol 2009; 46: 64–75.

3. Thomas DA . Philadelphia chromosome positive acute lymphocytic leukemia: a new era of challenges. Hematology Am Soc Hematol Educ Program 2007, 435–443.

4. Furukawa Y, Vu HA, Akutsu M, Odgerel T, Izumi T, Tsunoda S et al. Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus -negative leukemia cell lines. Leukemia 2007; 21: 1005–1014.

5. Cilloni D, Martinelli G, Messa F, Baccarani M, Saglio G . Nuclear factor kB as a target for new drug development in myeloid malignancies. Haematologica 2007; 92: 1224–1229.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pifithrin-µ Induces Stress Granule Formation, Regulates Cell Survival, and Rewires Cellular Signaling;Cells;2024-05-21

2. Heat Shock Proteins, a Double-Edged Sword: Significance in Cancer Progression, Chemotherapy Resistance and Novel Therapeutic Perspectives;Cancers;2024-04-14

3. Genetic heterogeneity in p53-null leukemia increases transiently with spindle assembly checkpoint inhibition and is not rescued by p53;Chromosoma;2023-05-31

4. Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?;Biomolecules;2023-03-28

5. HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances;Biomolecules;2023-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3